section name header

Basic Information

Author: Fred F. Ferri, MD

Definition

Cholelithiasis is the presence of stones in the gallbladder.

Synonym

  • Gallstones
ICD-10CM CODES
K80.80Other cholelithiasis without obstruction
K80.81Other cholelithiasis with obstruction
K91.86Retained cholelithiasis following cholecystectomy
Epidemiology & Demographics

  • Gallstone disease can be found in 12% of the U.S. population. Of these, 2% to 3% (500,000 to 600,000) are treated with cholecystectomies each year.
  • Annual medical expenditures for gallbladder surgeries in the U.S. exceed $5 billion.
  • Incidence of gallbladder disease increases with age. Highest incidence is in the fifth and sixth decades. Predisposing factors for gallstones are female sex, pregnancy, age >40 yr, family history of gallstones, obesity, ileal disease, oral contraceptives, diabetes mellitus, rapid weight loss, estrogen replacement therapy.
  • Patients with gallstones have a 20% chance of developing biliary colic or its complications at the end of a 20-yr period. Significant predictors of gallstone-related events are large stone (>10 mm), presence of multiple stones, and female sex.
Physical Findings & Clinical Presentation (Table 1

  • Physical examination is entirely normal unless patient is having biliary colic; 80% of gallstones are asymptomatic.
  • Typical symptoms of obstruction of the cystic duct include intermittent, severe, cramping pain affecting the right upper quadrant.
  • Pain occurs mostly at night and may radiate to the back or right shoulder. It can last from a few minutes to several hours.
  • Symptoms of gallstone disease and its complications are described in Table 2 and Fig. E1.

TABLE 2 Symptoms of Gallstone Disease and Its Complications

DiseasePathophysiologySymptoms
Biliary colicTransient gallstone impaction at the cystic duct or ampulla of VaterIntermittent right upper quadrant pain associated with nausea or vomiting. Pain in the epigastrium or radiating to the right scapular tip. Episodes last 30 min to several hours with days or months between episodes.
Acute cholecystitisInflammation of the gallbladder caused by obstruction of the cystic duct. May occur in the presence or absence of bacterial superinfectionPatients appear ill and cannot take deep breaths. They have constant pain that lasts 30-60 min and worsens with movement. Persistent common bile duct impaction usually promotes vomiting. Physical examination demonstrates right upper quadrant tenderness with voluntary guarding and a positive Murphy sign (arrest of inspiration during deep palpation over the gallbladder).
Emphysematous cholecystitisInfection with gas-producing bacteria such as Escherichia coli, Clostridium perfringens, and anaerobic streptococciSymptoms are similar to those with acute cholecystitis. Gas may be seen on abdominal plain films or CT. Male diabetics are most commonly affected.
Chronic cholecystitisPersistent inflammation and fibrosis of the gallbladder with poor motor and absorptive functionPatients are usually asymptomatic but may report multiple previous attacks of colic. Porcelain gallbladder develops from chronic inflammation and may progress to carcinoma.
Acalculous cholecystitisProbably related to biliary stasis in the setting of critical illness and altered gastrointestinal motilitySeen in patients with traumatic injuries, burns, and critical illness, as well as in those receiving total parenteral nutrition. The mortality for this disorder is twice as high as that for acute calculous cholecystitis.
Gallbladder perforationStones erode through an inflamed and necrotic gallbladder wall. Stones may travel into the peritoneal cavity or cause adhesions between nearby structures. Bile peritonitis may developMore than half of patients with gallbladder perforation have fever and a palpable right upper quadrant mass. Mortality in these patients is 30%.

CT, Computed tomography.

From Adams JG et al: Emergency medicine, clinical essentials, ed 2, Philadelphia, 2013, Elsevier.

Figure E1 Schematic depiction of the natural history and complications of gallstones.

Percentages indicate approximate frequencies of complications that occur in persons with gallstones, based on natural history data. The most frequent outcome is for the patient with a stone to remain asymptomatic throughout life. (1) Asymptomatic or biliary pain, (2) acute cholecystitis, (3) cholangitis, and (5) pancreatitis are the most common complications. (4) Mirizzi syndrome, (6) cholecystoenteric fistula, (6) Bouveret syndrome, and (7) gallbladder cancer are uncommon. The sum of percentages is >100% because patients with acute cholecystitis generally have had prior episodes of biliary pain.

(From Feldman M et al: Sleisenger and Fordtrans gastrointestinal and liver disease, ed 11, Philadelphia, 2021, Elsevier.)

TABLE 1 Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment of Gallstone Disease

Biliary painAcute CholecystitisCholedocholithiasisCholangitis
Pathophysiology
  • Intermittent obstruction of the cystic duct
  • No acute inflammation of the gallbladder
  • Impacted stone in the cystic duct
  • Acute inflammation of the gallbladder
  • Secondary bacterial infection in 50%
  • Stone passed from the gallbladder via the cystic duct or formed in the BD
  • Intermitted obstruction of the BD
  • A stone in the BD causing bile stasis
  • Bacterial superinfection of stagnant bile
  • Early bacteremia
Symptoms
  • Severe, poorly localized, epigastric or right upper quadrant visceral pain growing in intensity over 15 min and remaining constant for 1-6 h, often with nausea
  • Frequency of attacks varies from days to months
  • Gas, bloating, flatulence, and dyspepsia are not related to stones
  • 75% of cases are preceded by attacks of biliary pain
  • Visceral epigastric pain gives way to moderately severe localized pain in the right upper quadrant, back, right shoulder, or, rarely, chest
  • Nausea with some vomiting is frequent
  • Pain lasting >6 h favors cholecystitis over biliary pain alone
  • Often asymptomatic
  • Symptoms (when present) are indistinguishable from biliary pain
  • Predisposes to cholangitis and acute pancreatitis
  • Charcot triad (pain, jaundice, and fever) is present in 70% of patients
  • Pain may be mild and transient and is often accompanied by chills
  • Mental confusion, lethargy, and delirium suggest sepsis
Physical findings
  • Mild-to-moderate epigastric/right upper quadrant tenderness during an attack, with mild residual tenderness lasting days
  • Often, findings are normal
  • Fever, but usually to <102°F unless complicated by gangrene or perforation
  • Right subcostal tenderness with inspiratory arrest (Murphy sign)
  • Palpable gallbladder in 33% of patients, especially those having their first attack
  • Mild jaundice in 20%; higher frequency in older adults
  • Often findings are completely normal if the obstruction is intermittent
  • Jaundice with pain suggests stones; painless jaundice and a palpable gallbladder favor malignancy
  • Fever in 95%, right upper quadrant tenderness in 90%
  • Jaundice in 80%
  • Peritoneal signs in 15%
  • Hypotension and mental confusion (forming Reynolds pentad in combination with Charcot triad) coexist in 15% and suggest gram-negative sepsis
Laboratory findings
  • Usually normal
  • Elevated serum bilirubin, alkaline phosphatase, or amylase levels suggest coexisting BD stones
  • Leukocytosis with band forms is common
  • Serum bilirubin level may be 2-4 mg/dl, and aminotransferase and alkaline phosphatase levels may be elevated even in the absence of a BD stone or hepatic infection
  • Mild serum amylase and lipase elevations are seen even in the absence of pancreatitis
  • If serum bilirubin is >4 mg/dl or amylase or lipase is markedly elevated, a BD stone should be suspected
  • Elevated serum bilirubin and alkaline phosphatase levels are seen with BD obstruction
  • Serum bilirubin level >10 mg/dl suggests malignant obstruction or coexisting hemolysis
  • A transient "spike" in serum aminotransferase or amylase (or lipase) levels suggests the passage of a stone
  • Leukocytosis in 80%, but the remainder may have a normal WBC count with or without band forms
  • Serum bilirubin level is >2 mg/dl in 80%
  • Serum alkaline phosphatase level is usually elevated
  • Blood cultures are usually positive, especially during chills or a fever spike; 2 organisms are grown in cultures from half of patients
Diagnostic studies
  • US
  • Oral cholecystography
  • Meltzer-Lyon test
  • US
  • Hepatobiliary scintigraphy
  • Abdominal CT
  • ERCP
  • EUS
  • MRC
  • Percutaneous THC
  • ERCP
  • Percutaneous THC
Natural history
  • After the initial attack, 30% of patients have no further symptoms
  • Symptoms develop in the remainder at a rate of 6% per yr, and severe complications at a rate of 1%-2% per yr
  • 50% of cases resolve spontaneously in 7-10 days without surgery
  • Left untreated, 10% of cases are complicated by a localized perforation and 1% by a free perforation and peritonitis
  • The natural history is not well defined, but complications are more common and more severe than for asymptomatic stones in the gallbladder
  • A high mortality rate if unrecognized, with death from septicemia
  • Emergency decompression of the BD (usually by ERCP) improves survival dramatically
TreatmentElective laparoscopic cholecystectomy, possibly with IOC
ERCP for stone removal or BD exploration if IOC shows stones
Laparoscopic cholecystectomy, possibly with IOC if feasible; otherwise open cholecystectomyBD exploration or ERCP for stone removal if IOC shows stonesStone removal at the time of ERCP, followed in most cases by early laparoscopic cholecystectomyEmergency ERCP with stone removal or at least biliary decompression
Antibiotics to cover gram-negative and possibly anaerobic organisms and Enterococcus spp.
Subsequent cholecystectomy

BD, Bile duct; CT, computed tomography; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; IOC, intraoperative cholangiography; MRC, magnetic resonance cholangiography; THC, transhepatic cholangiography; US, ultrasound; WBC, white blood cells.

From Feldman M et al: Sleisenger and Fordtran’s gastrointestinal and liver disease, ed 11, Philadelphia, 2021, Elsevier.

Etiology

  • 75% of gallstones contain cholesterol and are usually associated with obesity, female sex, and diabetes mellitus; mixed stones are most common (80%); pure cholesterol stones account for only 10% of stones and are the result of biliary supersaturation due to cholesterol secretion into the gallbladder and accelerated cholesterol nucleation and crystallization.
  • 25% of gallstones are pigment stones (bilirubin, calcium, and variable organic material) associated with hemolysis and cirrhosis. These tend to be black-pigmented stones that are refractory to medical therapy.
  • 50% of mixed-type stones are radiopaque.

Diagnosis

Differential Diagnosis

  • Peptic ulcer disease
  • Gastroesophageal reflux disease
  • Irritable bowel disease
  • Pancreatitis
  • Neoplasms
  • Nonnuclear dyspepsia
  • Inferior wall myocardial infarction
  • Hepatic abscess
Laboratory Tests

Generally normal unless patient has biliary obstruction (elevated alkaline phosphatase, bilirubin)

Imaging Studies

  • Ultrasound of the gallbladder (Figs. E2 and E3) will detect small stones and biliary sludge (sensitivity, 95%; specificity, 90%); the presence of dilated gallbladder with thickened wall is suggestive of acute cholecystitis.
  • Nuclear imaging (HIDA scan) can confirm acute cholecystitis (>90% accuracy) if gallbladder does not visualize within 4 h of injection and the radioisotope is excreted in the common bile duct.
  • Common bile duct stones can be detected noninvasively by magnetic resonance cholangiopancreatography or invasively by endoscopic retrograde cholangiopancreatography (ERCP) and intraoperative cholangiography.

Figure E2 Gallbladder with Gallstones (Stones), Thickened Gallbladder Wall (Gbw), and Pericholecystic Fluid (Ff)

Together with a Sonographic Murphy Sign, These Findings Constitute the Sonographic Findings in Cholecystitis.

(From Walls RM et al: Rosen’s emergency medicine, concepts and clinical practice, ed 10, Philadelphia, 2023, Elsevier.)

Figure E3 Ultrasound image of a gallstone in the gallbladder neck.

The sharp echogenic wall of the gallstone (arrow), with the characteristic posterior shadowing stripe under the stone, helps differentiate it from other intraluminal findings.

(From Townsend CM et al: Sabiston textbook of surgery, ed 21, St Louis, 2022, Elsevier.)

Treatment

Nonpharmacologic Therapy

Lifestyle changes (avoidance of diets high in polyunsaturated fats, weight loss in obese patients; however, avoid rapid weight loss)

Acute General Rx

  • The management of gallstones is affected by the clinical presentation.
  • Asymptomatic patients do not require therapeutic intervention. Proposed criteria for prophylactic cholecystectomy are described in Table E3.
  • Surgical intervention is generally the ideal approach for symptomatic patients. Laparoscopic cholecystectomy is preferred over open cholecystectomy because of the shorter recovery period and lower mortality rate. Between 5% and 26% of patients undergoing elective laparoscopic cholecystectomy will require conversion to an open procedure. Most common reason is the inability to clearly identify the biliary anatomy.
  • Laparoscopic cholecystectomy after endoscopic sphincterectomy is recommended for patients with common bile duct stones and residual gallbladder stones. Where possible, single-stage laparoscopic treatments with removal of duct stones and cholecystectomy during the same procedure are preferable. Percutaneous cholecystectomy is an alternative for patients who are critically ill with gallbladder empyema and sepsis.
  • Patients who are not appropriate candidates for surgery because of coexisting illness or patients who refuse surgery can be treated with oral bile salts: Ursodiol or chenodiol. Candidates for oral bile salts are patients with cholesterol stones (radiolucent, noncalcified stones), with a diameter of 15 mm and having three or fewer stones. Candidates for medical therapy must have a functioning gallbladder and must have absence of calcifications on CT scans.
  • Extracorporeal shock wave lithotripsy (ESWL) is another form of medical therapy. It can be used in patients with stone diameter of 3 cm and having three or fewer stones.

TABLE E3 Proposed Criteria for Prophylactic Cholecystectomy

Life expectancy >20 yr
Calculi >2 cm in diameter
Calculi >3 mm and patent cystic duct
Radiopaque calculi
Gallbladder polyps >15 mm
Nonfunctioning or calcified gallbladder ("porcelain" gallbladder)
Women <60 yr
Patients in areas with high prevalence of gallbladder cancer

From Cameron JL, Cameron AM: Current surgical therapy, ed 14, Philadelphia, 2023, Saunders.

Disposition

  • Complicated gallstone events develop in 8% of patients with incidentally discovered gallstones after 17 yr.
  • After ESWL, stones recur in approximately 20% of patients after 4 yr.
  • Patients with at least one gallstone <5 mm in diameter have a greater than fourfold increased risk of presenting with acute biliary pancreatitis. A policy of watchful waiting in such cases is generally warranted.
  • A potential serious complication of gallstones is acute cholangitis. ERCP and endoscopic sphincterectomy followed by interval laparoscopic cholecystectomy are effective in acute cholangitis.
  • Uncommon complications of gallstone disease are summarized in Table 4.

TABLE 4 Uncommon Complications of Gallstone Disease

ComplicationPathogenesisClinical FeaturesDiagnosis/Treatment
Emphysematous cholecystitis
  • Secondary infection of the gallbladder wall with gas-forming organisms (Clostridium welchii, Escherichia coli, and anaerobic streptococci)
  • More common in older adult diabetic men; can occur without stones
  • Symptoms and signs similar to those of severe acute cholecystitis
  • Plain abdominal films may show gas in the gallbladder fossa
  • US and CT are sensitive for confirming gas
  • Treatment is with IV antibiotics, including anaerobic coverage, and early cholecystectomy
  • High morbidity and mortality rates
Cholecystoenteric fistula
  • Erosion of a (usually large) stone through the gallbladder wall into the adjacent bowel, most often the duodenum, followed in frequency by the hepatic flexure, stomach, and jejunum
  • Symptoms and signs similar to those of acute cholecystitis, although sometimes a fistula may be clinically silent
  • Stones >25 mm, especially in older adult women, may produce a bowel obstruction, or "gallstone ileus"; the terminal ileum is the most common site of obstruction
  • Gastric outlet obstruction (Bouveret syndrome) may occur rarely
  • Plain abdominal films may show gas in the biliary tree and/or a small bowel obstruction in gallstone ileus, as well as a stone in the right lower quadrant if the stone is calcified
  • Contrast upper GI series may demonstrate the fistula
  • A fistula from a solitary stone that passes may close spontaneously
  • Cholecystectomy and bowel closure are curative
  • Gallstone ileus requires emergency laparotomy; the diagnosis is often delayed, with a resulting mortality rate of 20%
Mirizzi syndrome
  • An impacted stone in the gallbladder neck or cystic duct, with extrinsic compression of the common hepatic duct from accompanying inflammation or fistula
  • Jaundice and right upper quadrant pain
  • ERCP demonstrates dilated intrahepatic ducts and extrinsic compression of the common hepatic duct and possible fistula
  • Preoperative diagnosis is important to guide surgery and minimize the risk of BD injury
Porcelain gallbladder
  • Intramural calcification of the gallbladder wall, usually in association with stones
  • No symptoms attributable to the calcified wall per se, but carcinoma of the gallbladder is a late complication in 20%
  • Plain abdominal films or CT show intramural calcification of the gallbladder wall
  • Prophylactic cholecystectomy is indicated to prevent carcinoma

BD, Bile duct; CT, computed tomography; ERCP, endoscopic retrograde cholangiopancreatography; GI, gastrointestinal; IV, intravenous; US, ultrasound.

From Feldman M et al: Sleisenger and Fordtran’s gastrointestinal and liver disease, ed 11, Philadelphia, 2021, Elsevier.

Related Content